These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1032 related items for PubMed ID: 27278921
1. Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP). Breymann C, Milman N, Mezzacasa A, Bernard R, Dudenhausen J, FER-ASAP investigators. J Perinat Med; 2017 May 24; 45(4):443-453. PubMed ID: 27278921 [Abstract] [Full Text] [Related]
2. Efficacy and safety of ferric carboxymaltose versus ferrous sulfate for iron deficiency anemia during pregnancy: subgroup analysis of Korean women. Shim JY, Kim MY, Kim YJ, Lee Y, Lee JJ, Jun JK, Shin JC, Cho YK, Lee KY, Kim A, Song TB. BMC Pregnancy Childbirth; 2018 Aug 28; 18(1):349. PubMed ID: 30153811 [Abstract] [Full Text] [Related]
3. A Prospective Randomised Controlled Trial of a Single Intravenous Infusion of Ferric Carboxymaltose vs Single Intravenous Iron Polymaltose or Daily Oral Ferrous Sulphate in the Treatment of Iron Deficiency Anaemia in Pregnancy. Khalafallah AA, Hyppa A, Chuang A, Hanna F, Wilson E, Kwok C, Yan C, Gray Z, Mathew R, Falloon P, Dennis A, Pavlov T, Allen JC. Semin Hematol; 2018 Oct 28; 55(4):223-234. PubMed ID: 30502851 [Abstract] [Full Text] [Related]
4. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial. Van Wyck DB, Mangione A, Morrison J, Hadley PE, Jehle JA, Goodnough LT. Transfusion; 2009 Dec 28; 49(12):2719-28. PubMed ID: 19682342 [Abstract] [Full Text] [Related]
5. Comparative efficacy and safety of intravenous ferric carboxymaltose and iron sucrose for iron deficiency anemia in obstetric and gynecologic patients: A systematic review and meta-analysis. Shin HW, Go DY, Lee SW, Choi YJ, Ko EJ, You HS, Jang YK. Medicine (Baltimore); 2021 May 21; 100(20):e24571. PubMed ID: 34011020 [Abstract] [Full Text] [Related]
6. Randomized trial comparing ferric carboxymaltose vs oral ferrous glycine sulphate for postoperative anaemia after total knee arthroplasty. Bisbe E, Moltó L, Arroyo R, Muniesa JM, Tejero M. Br J Anaesth; 2014 Sep 21; 113(3):402-9. PubMed ID: 24780615 [Abstract] [Full Text] [Related]
7. FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Evstatiev R, Marteau P, Iqbal T, Khalif IL, Stein J, Bokemeyer B, Chopey IV, Gutzwiller FS, Riopel L, Gasche C, FERGI Study Group. Gastroenterology; 2011 Sep 21; 141(3):846-853.e1-2. PubMed ID: 21699794 [Abstract] [Full Text] [Related]
8. A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia. Onken JE, Bregman DB, Harrington RA, Morris D, Acs P, Akright B, Barish C, Bhaskar BS, Smith-Nguyen GN, Butcher A, Koch TA, Goodnough LT. Transfusion; 2014 Feb 21; 54(2):306-15. PubMed ID: 23772856 [Abstract] [Full Text] [Related]
9. Comparative efficacy and safety of intravenous ferric carboxymaltose and iron sucrose for the treatment of preoperative anemia in patients with menorrhagia: An open-label, multicenter, randomized study. Lee S, Ryu KJ, Lee ES, Lee KH, Lee JJ, Kim T. J Obstet Gynaecol Res; 2019 Apr 21; 45(4):858-864. PubMed ID: 30932300 [Abstract] [Full Text] [Related]
10. Efficacy and safety of ferric carboxymaltose in correcting iron-deficiency anemia: a review of randomized controlled trials across different indications. Bailie GR. Arzneimittelforschung; 2010 Apr 21; 60(6a):386-98. PubMed ID: 20648930 [Abstract] [Full Text] [Related]
11. Intravenous versus oral iron for anaemia among pregnant women in Nigeria (IVON): an open-label, randomised controlled trial. Afolabi BB, Babah OA, Adeyemo TA, Balogun M, Banke-Thomas A, Abioye AI, Akinajo OR, Galadanci HS, Quao RA, Adelabu H, Sam-Agudu NA, Adaramoye VO, Abubakar A, Banigbe B, Olorunfemi G, Beňová L, Larsson EC, Annerstedt KS, Hanson C, Thornton J, IVON Trial Investigators. Lancet Glob Health; 2024 Oct 21; 12(10):e1649-e1659. PubMed ID: 39304237 [Abstract] [Full Text] [Related]
17. A meta-analysis of ferric carboxymaltose versus other intravenous iron preparations for the management of iron deficiency anemia during pregnancy. Gupte S, Mukhopadhyay A, Puri M, Gopinath PM, Wani R, Sharma JB, Swami OC. Rev Bras Ginecol Obstet; 2024 Oct 21; 46():. PubMed ID: 38765534 [Abstract] [Full Text] [Related]
18. Intravenous ferric carboxymaltose for anaemia in pregnancy. Froessler B, Collingwood J, Hodyl NA, Dekker G. BMC Pregnancy Childbirth; 2014 Mar 25; 14():115. PubMed ID: 24667031 [Abstract] [Full Text] [Related]
19. Comparison of efficacy and safety between intravenous ferric carboxymaltose and saccharated ferric oxide in Japanese patients with iron-deficiency anemia due to hypermenorrhea: a multi-center, randomized, open-label noninferiority study. Ikuta K, Hanashi H, Hirai K, Ota Y, Matsuyama Y, Shimura A, Terauchi M, Momoeda M. Int J Hematol; 2019 Jan 25; 109(1):41-49. PubMed ID: 30039442 [Abstract] [Full Text] [Related]
20. Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia. Breymann C, Gliga F, Bejenariu C, Strizhova N. Int J Gynaecol Obstet; 2008 Apr 25; 101(1):67-73. PubMed ID: 18234203 [Abstract] [Full Text] [Related] Page: [Next] [New Search]